2021 Report on Retinal Degeneration Drugs in Development – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Retinal Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report als

Full Story →